- Home
- RCUS vs BTBT Comparison
RCUS vs BTBT Comparison
Compare RCUS & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- BTBT
- Stock Information
- Founded
- RCUS 2015
- BTBT 2015
- Country
- RCUS United States
- BTBT United States
- Employees
- RCUS N/A
- BTBT N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- BTBT Finance: Consumer Services
- Sector
- RCUS Health Care
- BTBT Finance
- Exchange
- RCUS Nasdaq
- BTBT Nasdaq
- Market Cap
- RCUS 906.4M
- BTBT 1.1B
- IPO Year
- RCUS 2018
- BTBT 2018
- Fundamental
- Price
- RCUS $9.60
- BTBT $3.27
- Analyst Decision
- RCUS Buy
- BTBT Strong Buy
- Analyst Count
- RCUS 8
- BTBT 3
- Target Price
- RCUS $20.86
- BTBT $6.33
- AVG Volume (30 Days)
- RCUS 891.1K
- BTBT 69.5M
- Earning Date
- RCUS 08-07-2025
- BTBT 08-18-2025
- Dividend Yield
- RCUS N/A
- BTBT N/A
- EPS Growth
- RCUS N/A
- BTBT N/A
- EPS
- RCUS N/A
- BTBT N/A
- Revenue
- RCUS $141,000,000.00
- BTBT $102,037,923.00
- Revenue This Year
- RCUS N/A
- BTBT $20.87
- Revenue Next Year
- RCUS $28.73
- BTBT $38.28
- P/E Ratio
- RCUS N/A
- BTBT N/A
- Revenue Growth
- RCUS N/A
- BTBT 52.44
- 52 Week Low
- RCUS $6.50
- BTBT $1.69
- 52 Week High
- RCUS $18.98
- BTBT $5.74
- Technical
- Relative Strength Index (RSI)
- RCUS 53.46
- BTBT 53.92
- Support Level
- RCUS $9.14
- BTBT $3.12
- Resistance Level
- RCUS $9.62
- BTBT $4.49
- Average True Range (ATR)
- RCUS 0.44
- BTBT 0.44
- MACD
- RCUS 0.04
- BTBT 0.01
- Stochastic Oscillator
- RCUS 62.85
- BTBT 43.78
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.